Boeing
BA
$192.28
+0.95%
Boeing is a global aerospace and defense prime operating three segments: Commercial Airplanes (competing with Airbus in the 130+ seat jet market), Defense, Space & Security (military aircraft, satellites, and weapons competing with Lockheed Martin and Northrop Grumman), and Global Services, which provides aftermarket support to airlines. As one of only two Western large commercial airframe OEMs, Boeing holds a duopoly position in narrowbody and widebody jets, giving it structural pricing power and a massive installed base that feeds its higher-margin services business. The current investor narrative centers on a multi-year operational turnaround: 737 production rates are recovering, labor tensions are easing after new contracts were signed, and defense wins such as the JATM procurement deal are adding backlog, yet the stock has de-rated sharply on strike risk, cash burn, and lingering execution concerns. Debate now hinges on whether improving deliveries and services mix can translate into durable free cash flow before balance-sheet leverage and certification timelines force further equity dilution.…
BA
Boeing
$192.28
Related headlines
Investment Opinion: Should I buy BA Today?
Rating: Hold with a constructive bias. The core thesis is that Boeing's duopoly franchise and recovering deliveries (Q2 2026 revenue +7.96% YoY to $24.56 billion) offer substantial long-term value, but the balance sheet (9.98x debt-to-equity, -$210 million TTM FCF) and strike/certification risk mean the recovery is not yet de-risked. The analyst consensus of Buy (mean 1.52) with an average target of $268.15 (41% upside) anchors a favorable risk/reward for patient investors, but the stock's position at just 17.3% of its 52-week range argues against chasing.
Supporting evidence: (1) valuation is depressed on sales at 1.85x PS and 1.90x EV/Sales, near the bottom of Boeing's historical 4.5x-8.5x band, though the comparison is distorted by dilution; (2) revenue is growing 7.96% YoY with Q2 2026 at $24.56 billion; (3) Q2 2026 free cash flow turned positive at +$631 million versus -$1.45 billion in Q1; (4) the $268.15 average target implies 41% upside, and even the $206 low target is 8.3% above spot. Against this, the forward PE of 50.4x and EV/EBITDA of 28.4x show the market is already paying for a recovery that has not yet been delivered.
Key risks that could invalidate the thesis: an October engineering strike halting 737 production, a certification delay, or a Q3/Q4 cash-flow reversal that forces equity dilution. This Hold would upgrade to Buy if Q3 2026 free cash flow stays positive and 737 deliveries accelerate, or if the stock retests the $176.77 52-week low with stabilizing fundamentals; it would downgrade to Sell if TTM free cash flow deteriorates below -$1 billion or debt-to-equity rises further. Verdict: fairly valued to modestly undervalued relative to history, but expensive relative to current earnings—a turnaround bet, not a value trap or a bargain.
Sign up to view all
BA 12-Month Price Forecast
Boeing is a high-quality franchise trading at a depressed 1.85x sales multiple, but the forward PE of 50.4x and 9.98x debt-to-equity show the market is paying for a recovery that hinges on execution. The Q2 2026 free cash flow inflection to +$631 million and 7.96% revenue growth are genuine positives, yet the stock's position at just 17.3% of its 52-week range and -28.42% YTD relative strength versus the S&P 500 reflect deep skepticism. The wide $206-$305 analyst target range captures the binary nature of the strike and certification outcomes. I would upgrade to bullish if Q3 2026 confirms positive free cash flow and 737 deliveries accelerate; I would downgrade to bearish if a strike or charge pushes FCF negative and the 52-week low of $176.77 breaks.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Boeing's 12-month outlook, with a consensus price target around $267.22 and implied upside of +39.0% versus the current price.
Average Target
$267.22
0 analysts
Implied Upside
+39.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$206 - $305
Analyst target range
Coverage is robust, with 27 analysts and a consensus recommendation of Buy (mean rating 1.52 on a 1–5 scale where 1 is Strong Buy). The average target price of $268.15 implies roughly +41% upside from the $190.21 current price, a spread that signals the sell side is positioned for a sharp recovery even as the stock trades near its 52-week low. Consensus 2027 EPS of $14.56 and revenue of $146.5 billion underpin that optimism, and recent actions lean constructive: Argus upgraded to Buy from Hold in August, BNP Paribas moved to Outperform from Underperform, and Jefferies, BofA, JPMorgan, and RBC reiterated Buy/Overweight ratings through September.
The target range of $206 to $305 is wide, spanning about 48% of the midpoint, which reflects genuine uncertainty over strike outcomes, certification timing, and cash-flow recovery. The $305 high target assumes successful labor resolution, accelerating 737/787 deliveries, defense backlog conversion, and multiple expansion toward historical norms, while the $206 low target prices in margin compression, continued cash burn, and competitive share loss to Airbus. Notably, even the low target sits above the current price, suggesting analysts view the selloff as overdone; however, the gap between the consensus and the market price indicates investors are discounting management's execution ability more heavily than the sell side, and the wide dispersion argues for position sizing discipline until delivery and cash-flow data confirm the recovery.
Drowning in data?
Find the real signal!
Bulls vs Bears: BA Investment Factors
The bear case currently has stronger near-term evidence: BA trades at $190.21, just 7.6% above its 52-week low, with a 9.98x debt-to-equity ratio, negative TTM free cash flow of -$210 million, and a 16.49% YTD decline that badly lags the S&P 500's +11.93%. The bull case rests on forward-looking recovery: 7.96% revenue growth, positive Q2 free cash flow of $631 million, and a $268.15 average analyst target implying 41% upside. The single most important tension is whether improving 737/787 deliveries and services mix can convert into durable free cash flow before balance-sheet leverage and certification timelines force further equity dilution. If Q3/Q4 cash flow confirms the Q2 inflection, the stock's depressed 1.85x sales multiple could re-rate sharply; if a strike or charge interrupts the recovery, the 52-week low of $176.77 is the next stop.
Bullish
- Analyst consensus implies 41% upside: 27 analysts rate BA a Buy (mean 1.52 on a 1-5 scale) with an average target of $268.15, roughly 41% above the $190.21 current price. Even the lowest target of $206 sits 8.3% above spot, indicating the sell side views the selloff as overdone.
- Revenue recovery is accelerating: Q2 2026 revenue of $24.56 billion rose 7.96% year-over-year from $22.75 billion, following Q1 2026's $22.22 billion and Q4 2025's $23.95 billion. The sequential improvement reflects recovering 737 deliveries and supports the multi-year turnaround thesis.
- Free cash flow turned positive in Q2: Q2 2026 generated +$631 million of free cash flow on $1.36 billion of operating cash flow against $733 million of capex, a sharp reversal from Q1 2026's -$1.45 billion. Continued deleveraging ($1.42 billion of debt repaid) and cash conversion are the key to avoiding dilution.
- Duopoly pricing power and services mix: Boeing is one of only two Western large commercial airframe OEMs, giving it structural pricing power. Global Services contributed $5.34 billion of Q2 2026 revenue at higher margins, and the installed base feeds recurring aftermarket demand that cushions cyclical swings.
Bearish
- Balance sheet leverage is extreme: Debt-to-equity stands at 9.98x with a current ratio of 1.19 and TTM free cash flow of -$210 million. Cash fell to $7.24 billion from $9.44 billion as Boeing repaid $1.42 billion of debt, leaving little cushion if cash burn resumes.
- Profitability remains thin and volatile: Q2 2026 gross margin was 9.83% (down from 11.46% in Q1) and the company posted a net loss of $444 million (EPS -$0.67). Q3 2025's gross margin of -10.21% shows how quickly charges can erase progress, and trailing net margin of 2.50% is far below aerospace prime norms.
- Valuation prices a dramatic inflection: The forward PE of 50.4x on 2027 EPS of $14.56 and EV/EBITDA of 28.4x leave no room for error. The 30.3x price-to-book reflects a nearly depleted equity base, and the 155.4x price-to-cash-flow underscores how little cash the business currently produces.
- Technical downtrend with relative weakness: BA is down 16.49% YTD versus the S&P 500's +11.93%, with relative strength of -28.42 YTD and -22.33 over six months. At $190.21 the stock sits at just 17.3% of its 52-week range ($176.77-$254.35), only 7.6% above the low, signaling persistent distribution.
BA Technical Analysis
Boeing is in a sustained downtrend, with the stock down 10.23% over the past year and 16.49% year-to-date, badly lagging the S&P 500's +15.53% one-year and +11.93% YTD returns. At $190.21, the shares sit at roughly 17.3% of the 52-week range of $176.77–$254.35, meaning they are trading in the bottom fifth of the annual band and only about 7.6% above the 52-week low. That positioning signals persistent distribution and a market unwilling to underwrite a recovery, leaving the stock vulnerable to a retest of the lows rather than a momentum breakout.
Short-term momentum confirms the weakness rather than diverging from it: the stock is down 5.82% over one month and 11.13% over three months, with relative strength versus SPY of -7.04 and -13.82 respectively, indicating accelerating underperformance. The six-month change of -14.85% and relative strength of -22.33 show the deterioration is not a brief pullback but a broadening trend, and the recent slide below $200 ahead of a strike deadline underscores headline-driven volatility. Volume of roughly 7.3 million shares and a short ratio of 1.96 suggest no extreme crowding on either side, but the absence of a positive momentum thrust leaves little technical evidence of a bottom.
Key support sits at the 52-week low of $176.77, roughly 7% below the current price; a breakdown there would likely trigger momentum-driven selling and open a new leg lower. Resistance is anchored at the 52-week high of $254.35, about 34% above spot, with intermediate supply likely near the $200–$210 area where the stock repeatedly failed in September. A beta of 1.257 means the stock is roughly 26% more volatile than the market, so position sizing should account for amplified drawdowns; the max drawdown of -26.87% over the period illustrates that risk in practice.
Beta
1.26
1.26x market volatility
Max Drawdown
-26.9%
Largest decline past year
52-Week Range
$177-$254
Price range past year
Annual Return
-11.5%
Cumulative gain past year
| Period | BA Return | S&P 500 |
|---|---|---|
| 1m | -4.4% | -0.1% |
| 3m | -8.1% | +4.7% |
| 6m | -17.3% | +8.3% |
| 1y | -11.5% | +15.2% |
| ytd | -15.6% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BA Fundamental Analysis
Revenue is growing but unevenly: Q2 2026 revenue of $24.56 billion rose 7.96% year-over-year from $22.75 billion, following Q1 2026 revenue of $22.22 billion and Q4 2025's $23.95 billion. The sequential and annual improvement reflects recovering 737 deliveries, and segment data show Commercial Airplanes at $11.75 billion, Defense, Space & Security at $7.48 billion, and Global Services at $5.34 billion, with commercial narrowbodies the primary swing factor. The trajectory supports the recovery thesis, but growth remains well below what a normalized duopoly should deliver, implying the investment case still depends on execution rather than demand.
Profitability is thin and volatile: Q2 2026 gross margin was 9.83% on $2.41 billion of gross profit, down from 11.46% in Q1 2026, and the company posted a net loss of $444 million (EPS -$0.67) versus a near-breakeven -$4 million in Q1. The Q4 2025 net income of $8.22 billion was driven by a $9.13 billion non-operating gain rather than operations, as evidenced by negative operating income of -$815 million that quarter, so headline profitability overstates core earnings power. Trailing net margin of 2.50% and operating margin of 4.79% remain far below aerospace prime norms, and the Q3 2025 gross margin of -10.21% shows how quickly charges can erase progress.
Balance-sheet risk is the central constraint: debt-to-equity stands at 9.98x, the current ratio is 1.19, and TTM free cash flow is -$210 million, though Q2 2026 alone generated +$631 million of FCF on $1.36 billion of operating cash flow against $733 million of capex. Cash of $7.24 billion at quarter-end fell from $9.44 billion as Boeing repaid $1.42 billion of debt, and the Q1 2026 FCF of -$1.45 billion highlights the seasonal and working-capital sensitivity of cash generation. ROE of 40.98% is distorted by a thin equity base, while ROA of -1.98% better reflects the underlying economics; the company remains dependent on internal cash conversion and continued deleveraging to avoid external financing.
Quarterly Revenue
$24.6B
2026-06
Revenue YoY Growth
+8.0%
YoY Comparison
Gross Margin
9.8%
Latest Quarter
Free Cash Flow
$-210000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BA Overvalued?
Because trailing net income is marginally positive (EPS $0.0135) but economically meaningless, the PE of 87.2x is not a useful anchor; the forward PE of 50.4x on consensus 2027 EPS of $14.56 is the more relevant earnings-based metric, while the PS of 1.85x and EV/Sales of 1.90x are the cleanest cross-cycle measures given the depressed earnings base. The gap between trailing and forward PE implies the market expects a dramatic earnings inflection, and the EV/EBITDA of 28.4x confirms that current cash earnings are far below normalized levels.
Against aerospace and defense peers, Boeing's 1.85x sales multiple is roughly in line with large-cap defense primes but sits at a premium to what its 2.50% net margin and 4.79% operating margin would ordinarily justify; the 30.3x price-to-book is extreme and reflects a nearly depleted equity base rather than franchise value. The PEG ratio of -0.77 is not meaningful given negative earnings growth, and the 155.4x price-to-cash-flow ratio underscores how little cash the business currently produces relative to its $165.5 billion market cap. The premium is effectively a call option on margin recovery toward historical high-single-digit operating margins, not a discount to fair value.
Historically, Boeing's PS ratio has ranged from roughly 4.5x to 8.5x over the past several years, so the current 1.85x appears near the bottom of its own band; however, that comparison is distorted because the historical ratios data reflect a different share count and market-cap basis, and the company's equity has been rebuilt through dilution. On a like-for-like basis, the stock is pricing in substantial skepticism, with the 52-week range of $176.77–$254.35 and the current price near the low end suggesting the market assigns limited probability to a clean recovery. Near historical lows can signal value, but here it more likely reflects genuine fundamental deterioration and balance-sheet risk.
PE
87.2x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
28.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are dominated by leverage and cash-flow fragility. Debt-to-equity of 9.98x, a current ratio of 1.19, and TTM free cash flow of -$210 million leave Boeing dependent on internal cash conversion to avoid external financing. Q2 2026's +$631 million FCF followed Q1 2026's -$1.45 billion, illustrating seasonal and working-capital sensitivity, while cash fell to $7.24 billion from $9.44 billion after $1.42 billion of debt repayment. Margin risk is equally acute: Q2 gross margin of 9.83% fell from 11.46% in Q1, and Q3 2025's -10.21% gross margin shows how quickly charges can erase progress, with trailing net margin at just 2.50%.
Market and competitive risks center on valuation compression and execution credibility. The forward PE of 50.4x and EV/EBITDA of 28.4x price in a dramatic earnings inflection toward 2027 EPS of $14.56, leaving little room for disappointment. Beta of 1.257 means BA is roughly 26% more volatile than the market, amplifying drawdowns; the stock's -26.87% max drawdown over the period illustrates this in practice. Competitive pressure from Airbus, strike risk (engineers authorized an October strike), and certification delays could each trigger multiple compression, while the stock's -28.42% YTD relative strength versus the S&P 500 shows investors are already rotating away.
Worst-case scenario: a prolonged engineering strike halts 737 production, certification slips, and a fresh charge pushes Q3/Q4 free cash flow back into negative territory, forcing equity issuance that dilutes the 791 million shares outstanding. In that chain, the stock would likely retest and break the 52-week low of $176.77, a decline of roughly 7% from the current $190.21, and could extend toward the analyst low target of $206 only if sentiment stabilizes; a more severe outcome would see the stock trade below the 52-week low toward the $160-$170 area, implying a loss of 10-16% from current levels. The -26.87% max drawdown provides a realistic historical benchmark for how far a sentiment-driven selloff can run.
FAQ
The most severe risk is balance-sheet fragility: debt-to-equity of 9.98x, a current ratio of 1.19, and -$210 million TTM free cash flow leave little cushion, and cash fell to $7.24 billion from $9.44 billion. Second is execution risk: engineers authorized an October strike, and certification delays could interrupt the 737 delivery recovery that drove Q2 2026 revenue growth of 7.96%. Third is margin volatility: Q2 2026 gross margin of 9.83% fell from 11.46% in Q1, and Q3 2025's -10.21% shows how quickly charges can erase progress. Fourth is valuation compression: the forward PE of 50.4x and EV/EBITDA of 28.4x leave no room for disappointment, and beta of 1.257 amplifies drawdowns, as the -26.87% max drawdown illustrates.
The 12-month forecast has three scenarios: a 30% probability bull case targeting $268-$305 on a successful labor resolution and accelerating deliveries, a 45% probability base case targeting $206-$268 on gradual recovery with free cash flow near breakeven, and a 25% probability bear case targeting $176.77-$206 on a strike or certification delay. The base case is most likely, assuming no prolonged strike and gross margin holding in the high-single digits. The key assumption behind it is that 737 deliveries recover gradually and Q2 2026's +$631 million free cash flow is not a one-off. The wide $206-$305 analyst range (48% of midpoint) reflects genuine uncertainty, so investors should size positions for the bear case rather than the average target.
BA is fairly valued to modestly undervalued relative to its own history but expensive relative to current earnings. The 1.85x PS and 1.90x EV/Sales sit near the bottom of Boeing's historical 4.5x-8.5x band, suggesting the market is pricing in substantial skepticism. However, the forward PE of 50.4x on 2027 EPS of $14.56 and EV/EBITDA of 28.4x show the market already expects a dramatic earnings inflection, and the 30.3x price-to-book reflects a nearly depleted equity base rather than franchise value. The 155.4x price-to-cash-flow underscores how little cash the business currently produces. The valuation implies the market expects margin recovery toward high-single-digit operating margins; if that fails to materialize, the stock is expensive, but if it succeeds, the sales multiple has room to re-rate.
From a risk/reward perspective, BA offers 41% upside to the $268.15 average analyst target, and even the $206 low target is 8.3% above the current $190.21 price. However, the stock sits just 7.6% above its 52-week low of $176.77, with a 9.98x debt-to-equity ratio and -$210 million TTM free cash flow, so the downside is real if a strike or charge interrupts the recovery. The forward PE of 50.4x means you are paying for a recovery that has not yet been proven. It is a good buy for long-term investors who can tolerate volatility (beta 1.257) and want exposure to a duopoly franchise at a depressed 1.85x sales multiple, ideally accumulating on weakness toward $176.77. It is not a good buy for short-term traders or those needing income, given the 0.20% dividend yield.
BA is best suited for long-term investment with a minimum holding period of 2-3 years, given the multi-year nature of the operational turnaround and certification timelines. The stock's beta of 1.257, -26.87% max drawdown, and 16.49% YTD decline make it unsuitable for short-term trading unless one is explicitly trading the strike headline or the $176.77 support level. The 0.20% dividend yield provides negligible income, so total return depends entirely on capital appreciation from the recovery. Earnings visibility is low—the $206-$305 target range spans 48% of the midpoint—so investors should expect volatility around quarterly deliveries and cash-flow reports. A staged accumulation approach, adding on weakness toward the 52-week low, fits the risk profile better than a single entry point.
